English
Insider transactions
EDGARTRANSCODE THERAPEUTICS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-19.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–5 of 5
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 Filed 2026-09-11 | Fitzgerald Thomas A Director · Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 185,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 185,000 | Direct (D) | No | F1
| Open filing 0001104659-26-107120 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | DEFJ, LLC 10% ownerCK Life Sciences Intl (Holdings) Inc 10% owner | CConversion of derivative security | Acquired (A) | 11,813,859 | — | — | 12,113,899 | Direct (D) | No | F1, F2, F3
| Open filing 0001104659-26-091078 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | DEFJ, LLC 10% ownerCK Life Sciences Intl (Holdings) Inc 10% owner | CConversion of derivative security | Acquired (A) | 2,020,582 | — | — | 14,134,481 | Direct (D) | No | F1, F2, F3
| Open filing 0001104659-26-091078 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | DEFJ, LLC 10% ownerCK Life Sciences Intl (Holdings) Inc 10% owner | CConversion of derivative security | Disposed (D) | 1,181.3859 | 0 | — | 0 | Direct (D) | No | F1, F2, F4, F3
| Open filing 0001104659-26-091078 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | DEFJ, LLC 10% ownerCK Life Sciences Intl (Holdings) Inc 10% owner | CConversion of derivative security | Disposed (D) | 202.0582 | 0 | — | 0 | Direct (D) | No | F1, F2, F3
| Open filing 0001104659-26-091078 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.
Showing 1–13 of 13
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Yorkville Advisors Global, LP | 75,786 SH | 127,320 dollars | Higher by 56,147 Prior quarter: 19,639 | Open filing 0001104659-26-126193 Filed 2026-11-12 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 10,207 SH | 17,148 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,545 SH | 10,996 dollars | Unchanged Prior quarter: 6,545 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 2,982 SH | 5,010 dollars | Unchanged Prior quarter: 2,982 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 2,650 SH | 4,452 dollars | Lower by 238 Prior quarter: 2,888 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 1,746 SH | 2,934 dollars | Higher by 1,069 Prior quarter: 677 | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| OSAIC HOLDINGS, INC. Partly reported under another manager | 270 SH | 453 dollars | Not in the prior quarter’s filings read | Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row |
| Robinhood Markets, Inc. | 102 SH | 168 dollars | Not in the prior quarter’s filings read | Open filing 0000950157-26-001278 Filed 2026-11-18 Dispute this row |
| WELLS FARGO COMPANY/MN Partly reported under another manager | 55 SH | 92 dollars | Unchanged Prior quarter: 55 | Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row |
| SBI Securities Co., Ltd. | 12 SH | 20 dollars | Unchanged Prior quarter: 12 | Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row |
| FMR LLC Partly reported under another manager | 11 SH | 18 dollars | Lower by 695 Prior quarter: 706 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| IFP Advisors, Inc Partly reported under another manager | 8 SH | 13 dollars | Not in the prior quarter’s filings read | Open filing 0001641866-26-000005 Filed 2026-10-16 Dispute this row |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 1 SH | 2 dollars | Not in the prior quarter’s filings read | Open filing 0001085146-26-000940 Filed 2026-11-13 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- MERCER GLOBAL ADVISORS INC /ADV 1,535 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| DEFJ, LLC Common Stock | 83.9 | 14,134,481.00 | 08/03/2026 Filed 2026-08-03 | SCHEDULE 13D/AAmendment 5 | Open filing 0001104659-26-089819 Dispute this row |
| CK Life Sciences Int'l., (Holdings) Inc. Common Stock | 83.9 | 14,134,481.00 | 08/03/2026 Filed 2026-08-03 | SCHEDULE 13D/AAmendment 5 | Open filing 0001104659-26-089819 Dispute this row |
| DEFJ, LLC Common Stock | 83.9 | 14,134,481.00 | 07/27/2026 Filed 2026-07-27 | SCHEDULE 13D/AAmendment 4 | Open filing 0001104659-26-087098 Dispute this row |
| CK Life Sciences Int'l., (Holdings) Inc. Common Stock | 83.9 | 14,134,481.00 | 07/27/2026 Filed 2026-07-27 | SCHEDULE 13D/AAmendment 4 | Open filing 0001104659-26-087098 Dispute this row |
| Elena Rosa Braci Common Stock, par value $0.0001 per share | 6.17 | 186,236.00 | 07/23/2026 Filed 2026-07-28 | SCHEDULE 13G | Open filing 0001493152-26-035075 Dispute this row |
| Daniel Eduardo Katzman Common Stock, par value $0.0001 per share | 5.16 | 155,611.00 | 07/23/2026 Filed 2026-07-28 | SCHEDULE 13G | Open filing 0001493152-26-035074 Dispute this row |
| Unleash Immuno Oncolytics, Inc. Common Stock, par value $0.0001 per share | 9.94 | 300,000.00 | 07/23/2026 Filed 2026-07-28 | SCHEDULE 13G | Open filing 0001493152-26-035076 Dispute this row |
| DEFJ, LLC Common Stock | 9.9 | 300,040.00 | 07/23/2026 Filed 2026-07-23 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-26-086266 Dispute this row |
| CK Life Sciences Int'l., (Holdings) Inc. Common Stock | 9.9 | 300,040.00 | 07/23/2026 Filed 2026-07-23 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-26-086266 Dispute this row |
| DEFJ, LLC Common Stock | 8.8 | 83,285.00 | 07/17/2026 Filed 2026-07-17 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-084636 Dispute this row |
| CK Life Sciences Int'l., (Holdings) Inc. Common Stock | 8.8 | 83,285.00 | 07/17/2026 Filed 2026-07-17 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-084636 Dispute this row |
| YA II PN, Ltd. Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| YA Global Investments II (U.S.), LP Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| Yorkville Advisors Global, LP Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| Yorkville Advisors Global II, LLC Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| YAII GP, LP Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| YAII GP II, LLC Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| Mark Angelo Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| SC-Sigma Global Partners, LP Common Stock, $0.0001 par value per share | 9.9 | 101,772.00 | 04/15/2026 Filed 2026-04-20 | SCHEDULE 13G | Open filing 0001104659-26-045551 Dispute this row |
| SABBY MANAGEMENT, LLC Common Stock | 4.9 | 41,601.00 | 12/31/2025 Filed 2026-01-07 | SCHEDULE 13G/AAmendment 1 | Open filing 0001535610-26-000003 Dispute this row |
| SABBY VOLATILITY WARRANT MASTER FUND LTD Common Stock | 4.9 | 41,601.00 | 12/31/2025 Filed 2026-01-07 | SCHEDULE 13G/AAmendment 1 | Open filing 0001535610-26-000003 Dispute this row |
| HAL MINTZ Common Stock | 4.9 | 41,601.00 | 12/31/2025 Filed 2026-01-07 | SCHEDULE 13G/AAmendment 1 | Open filing 0001535610-26-000003 Dispute this row |
| CK Life Sciences Int'l., (Holdings) Inc. Common Stock | 9.1 | 83,285.00 | 10/27/2025 Filed 2025-10-28 | SCHEDULE 13D/AAmendment 1 | Open filing 0001104659-25-103292 Dispute this row |
| DEFJ, LLC Common Stock | 9.1 | 83,285.00 | 10/27/2025 Filed 2025-10-28 | SCHEDULE 13D/AAmendment 1 | Open filing 0001104659-25-103292 Dispute this row |
| CK Life Sciences Int'l., (Holdings) Inc. Common Stock | 9.1 | 83,285.00 | 10/08/2025 Filed 2025-10-16 | SCHEDULE 13D | Open filing 0001104659-25-100081 Dispute this row |
| DEFJ, LLC Common Stock | 9.1 | 83,285.00 | 10/08/2025 Filed 2025-10-16 | SCHEDULE 13D | Open filing 0001104659-25-100081 Dispute this row |
| THE GOLDMAN SACHS GROUP, INC. Common Stock, par value $0.0001 per share | 0.0 | 82.00 | 09/30/2025 Filed 2025-11-10 | SCHEDULE 13G/AAmendment 1 | Open filing 0000886982-25-001440 Dispute this row |
| GOLDMAN SACHS CO. LLC Common Stock, par value $0.0001 per share | 0.0 | 82.00 | 09/30/2025 Filed 2025-11-10 | SCHEDULE 13G/AAmendment 1 | Open filing 0000886982-25-001440 Dispute this row |
| Anson Funds Management LP Common Stock, $0.0001 par value | 0.1 | 27,125 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950170-25-109220 Dispute this row |
| Anson Management GP LLC Common Stock, $0.0001 par value | 0.1 | 27,125 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950170-25-109220 Dispute this row |
| Tony Moore Common Stock, $0.0001 par value | 0.1 | 27,125 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950170-25-109220 Dispute this row |
| Anson Advisors Inc. Common Stock, $0.0001 par value | 0.1 | 27,125 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950170-25-109220 Dispute this row |
| Amin Nathoo Common Stock, $0.0001 par value | 0.1 | 27,125 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950170-25-109220 Dispute this row |
| Moez Kassam Common Stock, $0.0001 par value | 0.1 | 27,125 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950170-25-109220 Dispute this row |
| THE GOLDMAN SACHS GROUP, INC. Common Stock, par value $0.0001 per share | 5.9 | 49,018.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G | Open filing 0000769993-25-000533 Dispute this row |
| GOLDMAN SACHS CO. LLC Common Stock, par value $0.0001 per share | 5.9 | 49,018.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G | Open filing 0000769993-25-000533 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,540,664 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 166,957 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,403 |
Filings made before the SEC required XML are listed, not extracted.